T80.419A Rh incompatibility with hemolytic transfusion reaction, unspecified, initial encounter

Name of the Condition

• Rh incompatibility with hemolytic transfusion reaction, unspecified, initial encounter.

Summary

This condition describes an immune-mediated hemolytic reaction occurring when Rh-negative individuals receive Rh-positive blood or blood products, leading to the destruction of red blood cells (hemolysis). It results from the recipient’s immune system recognizing Rh antigens as foreign, triggering antibody production and subsequent hemolysis. The "unspecified" designation indicates the reaction’s timing is not further classified as acute or delayed, and "initial encounter" denotes the first episode of care.

Causes

The reaction is triggered by the presence of Rh-positive red blood cells in an Rh-negative recipient, which the immune system identifies as foreign. This initiates antibody production, causing hemolysis. Transfusions of whole blood, packed red blood cells, or plasma products containing Rh-positive cells are common sources.

Risk Factors

• Rh-negative blood type
• Prior exposure to Rh-positive blood (e.g., previous transfusions or pregnancy)
• Inadequate crossmatching or typing before transfusion
• Use of blood products with unknown Rh status

Symptoms

• Fever, chills, or rigors
• Jaundice or dark urine (hemoglobinuria)
• Anemia-related fatigue or pallor
• Shortness of breath or tachycardia
• Abdominal or back pain
• Elevated bilirubin levels (laboratory finding)

Diagnosis

Diagnosis involves confirming Rh incompatibility through blood typing and crossmatching, along with clinical assessment of transfusion history. Laboratory tests may include direct antiglobulin testing (Coombs test) and measurement of bilirubin or hemoglobin levels to detect hemolysis.

Treatment Options

Treatment focuses on stopping the transfusion immediately, managing symptoms (e.g., antipyretics for fever, fluids for renal protection), and addressing hemolysis (e.g., supportive care for anemia). In severe cases, additional interventions like dialysis may be required.

Prognosis and Follow-Up

Prognosis depends on the severity of hemolysis and promptness of treatment. Most cases resolve with appropriate care, but delayed or severe reactions may lead to complications. Follow-up includes monitoring for recurrence and ensuring future transfusions use Rh-compatible products.

Complications

• Acute kidney injury (from hemoglobinuria)
• Disseminated intravascular coagulation (DIC)
• Severe anemia requiring transfusion
• Shock or multiorgan failure (rare)

Lifestyle & Prevention

Prevention relies on rigorous blood typing and crossmatching before transfusion. Rh-negative individuals should receive Rh-negative blood products, and prior exposure history (e.g., pregnancy, transfusions) should be documented to guide compatibility testing.

When to Seek Professional Help

Seek immediate medical attention if symptoms like fever, chills, jaundice, or dark urine occur during or after a blood transfusion. These may indicate a hemolytic reaction requiring urgent intervention.

Tips for Medical Coders

Document the timing of the reaction (unspecified) and encounter type (initial) clearly. Ensure transfusion history, blood type results, and clinical findings supporting hemolysis are recorded. The code T80.419A is specific to the initial encounter for an unspecified hemolytic transfusion reaction due to Rh incompatibility.